Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 25, 2025
The Beam: Protons for head and neck cancers, a look at our RTTs, meet Angelle Schilling
When are protons indicated for head and neck cancers? A deeper look at the role of radiation therapists and an introduction to our newest nurse
New immunotherapy targets discovered for head and neck cancer
From the Prlic lab, Clinical Research and Vaccine and Infectious Disease Divisions
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology
Remembering Dr. Eddie Méndez
Hutch friends and colleagues recall brilliant physician-scientist and ‘bright, shining star’
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Good News: Dr. Eduardo Méndez receives $2.2M in NIH funding for targeted therapies for head and neck cancers
Celebrating faculty and staff achievements
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
HPV vaccine boosts immune memory
A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection
Forgotten patients: New guidelines help those with head-and-neck cancers
Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Patients treated at cancer centers live longer: study
Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’